MyHealthChecked PLC Confirmation of Capital Reduction (0373N)

TIDMMHC

RNS Number : 0373N

MyHealthChecked PLC

18 January 2023

MyHealthChecked PLC

( " MyHealthChecked " or the "Company " )

Confirmation of Capital Reduction

Further to the announcement made by the Company on 6 December 2022, MyHealthChecked PLC (AIM: MHC), announces today that the reduction of capital (the "Capital Reduction"), involving the cancellation of the Deferred Shares, the Share Premium Account and the Capital Redemption Reserve of the Company, has been confirmed by the High Court of Justice of England and Wales (the "Court").

The Court order confirming the Capital Reduction, and a statement of capital approved by the Court, is expected to be registered with the Registrar of Companies no later than 31 January 2023.

Full details of the Capital Reduction are set out in the notice of general meeting which was sent to shareholders of the Company on 18 November 2022 (the "Notice"). The Notice is also available for inspection on the Company's website.

For further information contact:

 
 MyHealthChecked PLC                                                www.myhealthchecked.com 
 Penny McCormick, Chief Executive                                           via Walbrook PR 
  Officer 
 
 SPARK Advisory Partners Limited                                   Tel: [phone] 
  (NOMAD) 
 Neil Baldwin 
 
 Dowgate Capital Limited (Broker                                   Tel: [phone] 
  ) 
 David Poutney / Nicholas Chambers 
 
 Walbrook PR Ltd (Media       Tel: [phone] or [e-mail] 
  & IR) 
 Paul McManus                                                      Mob: [phone] 
 
 

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FURNKOBBOBKDFDD

(END) Dow Jones Newswires

January 18, 2023 02:01 ET (07:01 GMT)